Adult attention-deficit hyperactivity disorder and obesity: Epidemiological study

British Journal of Psychiatry

Volumn 203, Issue 1, 2013, Pages 24-34

  Cortese, Samuele ^a,b,c   Faraone, Stephen V ^d   Bernardi, Silvia ^e   Wang, Shuai ^e   Blanco, Carlos ^e  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITÉ DE TOURS   (France)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULTHOOD; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BODY MASS; CLINICAL FEATURE; CONFOUNDING VARIABLE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; OBESITY; SOCIAL STATUS; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BODY MASS INDEX; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84879665025     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.112.123299     Document Type: Article

References (42)

1. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164: 942-8. (Pubitemid 46972911)
2. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006; 36: 159-65. (Pubitemid 43126140)
3. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237-48. (Pubitemid 40981053)
4. Cortese S, Vincenzi B. Obesity and ADHD: clinical and neurobiological implications. Curr Top Behav Neurosci 2012; 9: 199-218.
5. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998; 6 (suppl 2): 51S-209.
6. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011; 378: 815-25.
7. Levy LD, Fleming JP, Klar D. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. Int J Obes (Lond) 2009; 33: 326-34.
8. Simon GE, Von KM, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006; 63 : 824-30.
9. Fuemmeler BF, Ostbye T, Yang C, McClernon FJ, Kollins SH. Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study. Int J Obes (Lond) 2011; 35 : 852-62.
10. van Egmond-Frohlich AW, Widhalm K, de Zwaan M. Association of symptoms of attention-deficit/hyperactivity disorder with childhood overweight adjusted for confounding parental variables. Int J Obes (Lond) 2012; 36: 963-8.
11. Byrd HC, Curtin C, Anderson SE. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004. Pediatr Obes 2013, January 16 (epub ahead of print).
12. Kim J, Mutyala B, Agiovlasitis S, Fernhall B. Health behaviors and obesity among US children with attention deficit hyperactivity disorder by gender and medication use. Prev Med 2011; 52: 218-22.
13. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 361-8. (Pubitemid 38451545)
14. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 807-16. (Pubitemid 39031120)
15. Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry 2009; 14: 1051-66.
16. Grant B, Dawson D, Hasin D. The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions Alcohol Use Disorder and Associated Disabilities Interview Schedule - DSM-IV Version. National Institutes of Health, 2001 (http://www.niaaa.nih.gov.).
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
18. Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, et al. The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry 2010; 167: 14-6.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM-IV-TR). APA, 2000.
20. Ruan WJ, Goldstein RB, Chou SP, Smith SM, Saha TD, Pickering RP, et al. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend 2008; 92: 27-36. (Pubitemid 350218195)
21. World Health Organization. Obesity and Overweight. Factsheet 311. WHO, 2013 (http://www.who.int/mediacentre/factsheets/fs311/en/).
22. Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, et al. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med 2012; 42: 875-87.
23. Rojo L, Ruiz E, Dominguez JA, Calaf M, Livianos L. Comorbidity between obesity and attention deficit/hyperactivity disorder: population study with 13-15-year-olds. Int J Eat Disord 2006; 39: 519-22. (Pubitemid 44232272)
24. Pagoto SL, Curtin C, Lemon SC, Bandini LG, Schneider KL, Bodenlos JS, et al. Association between adult attention deficit/hyperactivity disorder and obesity in the US population. Obesity (Silver Spring) 2009; 17: 539-44.
25. Rosler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attentiondeficit/ hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006; 256 (suppl 1): i3-11.
26. Barkley RA, Murphy KR, Fischer M. ADHD in Adults: What the Science Says. Guilford, 2007.
27. Centers for Disease Control and Prevention. Vital signs: state-specific obesity prevalence among adults - United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59: 951-5.
28. de Zwaan M, Gruss B, Muller A, Philipsen A, Graap H, Martin A, et al. Association between obesity and adult attention-deficit/hyperactivity disorder in a German community-based sample. Obes Facts 2011; 4: 204-11.
29. Matte B, Rohde LA, Grevet EH. ADHD in adults: a concept in evolution. Atten Defic Hyperact Disord 2012; 4: 53-62.
30. Davis C, Levitan RD, Smith M, Tweed S, Curtis C. Associations among overeating, overweight, and attention deficit/hyperactivity disorder: a structural equation modelling approach. Eat Behav 2006; 7: 266-74.
31. Porrino LJ, Rapoport JL, Behar D, Sceery W, Ismond DR, Bunney Jr WE. A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 1983; 40: 681-7. (Pubitemid 13094937)
32. Neumark-Sztainer D, Wall M, Larson NI, Eisenberg ME, Loth K. Dieting and disordered eating behaviors from adolescence to young adulthood: findings from a 10-year longitudinal study. J Am Diet Assoc 2011; 111: 1004-11.
33. Haines J, Kleinman KP, Rifas-Shiman SL, Field AE, Austin SB. Examination of shared risk and protective factors for overweight and disordered eating among adolescents. Arch Pediatr Adolesc Med 2010; 164: 336-43.
34. Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010; 304: 875-80.
35. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167: 748-51.
36. Epstein JN, Kollins SH. Psychometric properties of an adult ADHD diagnostic interview. J Atten Disord 2006; 9: 504-14. (Pubitemid 43171143)
37. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885-90. (Pubitemid 23156767)
38. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002; 111: 279-89. (Pubitemid 34441206)
39. Mannuzza S, Klein RG, Klein DF, Bessler A, Shrout P. Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry 2002; 159: 1882-8. (Pubitemid 35283254)
40. Kuczmarski MF, Kuczmarski RJ, Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Diet Assoc 2001; 101: 28-34. (Pubitemid 33712693)
41. Bijlenga D, van der Heijden KB, Breuk M, van Someren EJW, Lie MEH, Boonstra AM, et al. Associations between sleep characteristics, seasonal depressive symptoms, lifestyle, and ADHD symptoms in adults. J Atten Disord 2013; 17: 261-75.
42. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004; 1: e62.